Researchers from University Department of Life Sciences and Public Health Describe Findings in Personalized Medicine (Integrating China in the International Consortium for Personalised Medicine: a position paper on innovation and digitalization...).

A new report from the University Department of Life Sciences and Public Health discusses the potential of personalized medicine (PM) to revolutionize healthcare by tailoring treatments to individual patients based on their data. The report highlights the need for the seamless integration of innovative technologies and collaboration between the European Union (EU) and China in the field of personalized medicine. A Delphi survey was conducted to identify key priorities for the implementation of personalized medicine, including data interoperability, standards, security measures, international partnerships, cost-effectiveness, and value assessment. The effective implementation of new technologies in personalized medicine is crucial for advancing healthcare systems in both Europe and China. [Extracted from the article]